# Switching to a Vaping Device: Evaluating Risk Reduction Among Quitline Treatment Failures

> **NCT03502200** · NA · COMPLETED · sponsor: **Ohio State University Comprehensive Cancer Center** · enrollment: 350 (actual)

## Conditions studied

- Smoking, Cigarette

## Interventions

- **DEVICE:** JUUL
- **OTHER:** Treatment As Usual

## Key facts

- **NCT ID:** NCT03502200
- **Lead sponsor:** Ohio State University Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-15
- **Primary completion:** 2023-01-31
- **Final completion:** 2023-01-31
- **Target enrollment:** 350 (ACTUAL)
- **Last updated:** 2023-07-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03502200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03502200, "Switching to a Vaping Device: Evaluating Risk Reduction Among Quitline Treatment Failures". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03502200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*